Menopause laboratory findings

	Menopause Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differential Diagnosis
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasonography
Other Imaging Findings
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Menopause laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Menopause laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Menopause laboratory findings
CDC on Menopause laboratory findings
Menopause laboratory findings in the news
Blogs on Menopause laboratory findings
Directions to Hospitals Treating Menopause
Risk calculators and risk factors for Menopause laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Rahmah Al-Edresi, M.D.[2]

Overview

An elevated serum of Follicle Stimulating Hormone (FSH) greater than 40 mIU/mL is diagnostic of menopause.
An elevated FSH level on two blood samples is diagnostic of premature menopause with intervals of about 4–6 weeks between samples
A decreased serum of the Anti-Mullerian Hormone level (AMH) is a diagnostic test of premature menopause and a low level of AMH is normal in the postmenopause period.
A decreased of estrogen Hormone level in women with menopause.
karyotype analysis and testing for an FMR1 for Fragile X syndrome.
Thyroid-stimulating hormone (TSH)

References